深圳市药品集中采购对降低药品费用的成效研究

目的:测算深圳市药品集中采购模式下药品降幅。方法:采用拉氏指数法,将同一通用名、同一目录剂型、同一质量层次药品纳入同组分析,计算其加权平均数。结果:在维持2015年销售数量不变的前提下,测算理论金额为53.78亿元,预计节约费用15.16亿元,综合降幅21.99%。结论:总体来说深圳市GPO是药品采购模式的有益探索,在降低药品总费用的基础上保障了临床用药需求。

Study on the effectiveness of GPO in reducing drug costs in Shenzhen

Objective: To quantify the decline of drugs under Group purchasing organizations operating with the centralized drug procurement model in Shenzhen. Method: Using the Laplace index method, drugs with the same generic name, the same catalogue dosage form and the same quality level were included in the same group analysis, and their weighted averages were quantified. Results: On the premise of keeping the sales volume unchanged in 2015, the theoretical amount was estimated to be 5.378 billion yuan, and the estimated cost savings were 1.516 billion yuan, which showed a comprehensive decline of 21.99%. Conclusions: Generally speaking, Shenzhen is a beneficial exploration of GPO mode of drug purchase, which can provide the demand guarantee for clinical medicines based on the reduction of total cost of drugs.